Literature DB >> 25423317

Prognostic significance of Sugarbaker's peritoneal cancer index for the operability of ovarian carcinoma.

Bjoern Lampe1, Nadine Kroll, Pompiliu Piso, Dirk Michael Forner, Peter Mallmann.   

Abstract

INTRODUCTION: This study aimed to investigate Sugarbaker's peritoneal cancer index (PCI) as a prognostic indicator for the resectability of ovarian carcinoma (OC), as depicted in the study using the completeness of cytoreduction score (CCS).Currently, the intraoperative assessment of operability in OC surgery is primarily a subjective measurement that is dependent on the surgeon.
METHODS: The retrospective data from 98 patients with OC International Federation of Gynecology and Obstetrics (FIGO) III to IV who had received surgery between January 2010 and December 2011 were analyzed. The PCI and the CCS were determined retrospectively using surgical reports, histological findings, and intraoperative photographic documentation. Receiver operating characteristic curves and ordinal regression were applied to evaluate the predictability of CCS using the PCI.
RESULTS: Of 98 patients, 80 (81.6%) were staged FIGO III and 18 (18.4%) FIGO IV. A statistically significant correlation was demonstrated between the PCI and CCS (P < 0.01). A receiver operating characteristic curve with an area under the curve of 0.839 demonstrated the high precision in discrimination with which the PCI could predict the CCS. Using ordinal regression, it was possible to estimate the probabilities of achieving CCS 0, CCS 1, CCS 2, or CCS 3 for a given PCI (pseudo R(2) according to Cox and Snell 0.428, Nagelkerke 0.476, and McFadden 0.244).
CONCLUSIONS: The PCI more precisely defined the heterogeneous group of patients with OC FIGO III. The PCI provided objectivity and reproducibility, and it seems to be a possible prognostic indicator for OC resectability.

Entities:  

Mesh:

Year:  2015        PMID: 25423317     DOI: 10.1097/IGC.0000000000000327

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  12 in total

Review 1.  Peritoneal Metastases from Gastrointestinal Cancer.

Authors:  Paul H Sugarbaker
Journal:  Curr Oncol Rep       Date:  2018-06-08       Impact factor: 5.075

2.  Prevention and Treatment of Peritoneal Metastases: a Comprehensive Review.

Authors:  Paul H Sugarbaker
Journal:  Indian J Surg Oncol       Date:  2019-01-03

3.  A Retrospective Clinical Analysis of Hyperthermic Intraperitoneal Chemotherapy in Gynecological Cancers: Technical Details, Tolerability, and Efficacy.

Authors:  Yagmur Minareci; Ozgur Aydın Tosun; Hamdullah Sozen; Samet Topuz; Mehmet Yavuz Salihoglu
Journal:  Medeni Med J       Date:  2020-09-30

4.  Risk Factors for Severe Complications in Ovarian Cancer Surgery.

Authors:  Eva Katharina Egger; Natascha Kohls; Matthias B Stope; Mateja Condic; Mignon-Denise Keyver-Paik; Dominique KÖnsgen; Tobias Hilbert; Sven Klaschik; Daniel Exner; Tim Vilz; Alexander Mustea
Journal:  In Vivo       Date:  2020 Nov-Dec       Impact factor: 2.155

5.  A predictive score for optimal cytoreduction at interval debulking surgery in epithelial ovarian cancer: a two- centers experience.

Authors:  Eleonora Ghisoni; Dionyssios Katsaros; Furio Maggiorotto; Massimo Aglietta; Marco Vaira; Michele De Simone; Gloria Mittica; Gaia Giannone; Manuela Robella; Sofia Genta; Fabiola Lucchino; Francesco Marocco; Fulvio Borella; Giorgio Valabrega; Riccardo Ponzone
Journal:  J Ovarian Res       Date:  2018-05-30       Impact factor: 4.234

6.  The Peritoneal Cancer Index is a Strong Predictor of Incomplete Cytoreductive Surgery in Ovarian Cancer.

Authors:  Björg Jónsdóttir; Marta Lomnytska; Inger Sundström Poromaa; Ilvars Silins; Karin Stålberg
Journal:  Ann Surg Oncol       Date:  2020-05-29       Impact factor: 5.344

7.  COVID-19 free oncologic surgical hub: The experience of reallocation of a gynecologic oncology unit during pandemic outbreak.

Authors:  Anna M Perrone; Giulia Dondi; Susanna Giunchi; Eugenia De Crescenzo; Safia Boussedra; Marco Tesei; Rocco D'Andrea; Antonio De Leo; Claudio Zamagni; Alessio G Morganti; Alessandra De Palma; Pierandrea De Iaco
Journal:  Gynecol Oncol       Date:  2020-11-19       Impact factor: 5.482

8.  Validation of 18F-FDG PET/MRI and diffusion-weighted MRI for estimating the extent of peritoneal carcinomatosis in ovarian and endometrial cancer -a pilot study.

Authors:  Björg Jónsdóttir; Montserrat Alemany Ripoll; Håkan Ahlström; Karin Stålberg; Antonina Bergman; Ilvars Silins; Inger Sundström Poromaa
Journal:  Cancer Imaging       Date:  2021-04-13       Impact factor: 3.909

9.  Peritoneal cancer index as a predictor of survival in advanced stage serous epithelial ovarian cancer: a prospective study.

Authors:  Alaa A Elzarkaa; Waleed Shaalan; Doaa Elemam; Hassan Mansour; Mahmoud Melis; Eduard Malik; Amr A Soliman
Journal:  J Gynecol Oncol       Date:  2018-03-08       Impact factor: 4.401

10.  ASO Author Reflections: Use of Peritoneal Cancer Index (PCI) to Evaluate Carcinomatosis in Ovarian Cancer.

Authors:  Karin Stålberg; Björg Jónsdóttir
Journal:  Ann Surg Oncol       Date:  2020-05-28       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.